| MeSH term | MeSH ID | Detail |
|---|---|---|
| Periapical Periodontitis | D010485 | 6 associated lipids |
| Hyperlipoproteinemia Type IV | D006953 | 6 associated lipids |
| Glomerulonephritis, Membranous | D015433 | 6 associated lipids |
| Behcet Syndrome | D001528 | 7 associated lipids |
| Agranulocytosis | D000380 | 7 associated lipids |
| Rhinitis, Allergic, Seasonal | D006255 | 7 associated lipids |
| Infant, Premature, Diseases | D007235 | 7 associated lipids |
| Biliary Tract Neoplasms | D001661 | 7 associated lipids |
| Femoral Fractures | D005264 | 7 associated lipids |
| Bronchopneumonia | D001996 | 7 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chou TC et al. | Mechanism of inhibition of platelet aggregation by HCL-31D. | 2000 | Eur. J. Pharmacol. | pmid:10650152 |
| Landoni MF et al. | Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep. | 1999 | J. Vet. Pharmacol. Ther. | pmid:10651463 |
| Hansen JM et al. | Effects of nitric oxide blockade and cyclosporin A on cardiovascular and renal function in normal man. | 1999 | J. Hypertens. | pmid:10658936 |
| Matsumoto H and Nakao T | Elevated urinary excretion of thromboxane B2 in adults with minimal-change nephrotic syndrome. | 2000 | Clin. Nephrol. | pmid:10661487 |
| Leese PT et al. | Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. | 2000 | J Clin Pharmacol | pmid:10664917 |
| Okumura M et al. | Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes. | 2000 | Life Sci. | pmid:10670825 |
| Wu TM et al. | Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation. | 2000 | Thromb. Res. | pmid:10674405 |
| De La Cruz JP et al. | Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus. | 2000 | Thromb. Res. | pmid:10680643 |
| Zeng W et al. | [Relationship between PGI2, TXA2 and threatened preterm]. | 1998 | Hua Xi Yi Ke Da Xue Xue Bao | pmid:10684102 |
| Nagano K et al. | Prostanoids regulate proliferation of vascular smooth muscle cells induced by arginine vasopressin. | 2000 | Eur. J. Pharmacol. | pmid:10686292 |